Entry Detail



General Information

Database ID:exR0080618
RNA Name:RPL8
RNA Type:mRNA
Chromosome:chr8
Starnd:-
Coordinate:
Start Site(bp):144789765End Site(bp):144792587
External Links:ENSG00000161016



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AHCY
chr20
34280268
34311802
-
ALDOA
chr16
30064164
30070457
+
AC124312.1
chr15
24955034
25000276
+
ACTB
chr7
5527148
5563784
-
AC105052.3
chr7
102637049
102671641
-
ALDH6A1
chr14
74056847
74084492
-
ADCK1
chr14
77800109
77935014
+
AC004922.1
chr7
99325879
99394653
+
ACTN1
chr14
68874143
68979440
-
AKIRIN1
chr1
38991276
39006059
+
AC092073.1
chr19
34396315
34409364
+
ADARB2
chr10
1177313
1737525
-
AIMP2
chr7
6009255
6023834
+
ACTN4
chr19
38647649
38731589
+
AC008982.1
chr19
38817471
38840178
-
AHSA1
chr14
77457870
77469472
+
ABHD12
chr20
25294742
25390835
-
AC027796.3
chr17
3585149
3636249
-
ACTG1
chr17
81509971
81523847
-
ACACA
chr17
37084992
37406836
-
ACTR5
chr20
38748460
38772520
+
ACTR2
chr2
65227753
65271253
+
AKAP8L
chr19
15380050
15419141
-
ADNP
chr20
50888916
50931437
-
AC011448.1
chr19
19516227
19536076
+
AL022238.4
chr22
40346529
40410054
+
AC018523.2
chr11
14493783
14520344
-
AGA
chr4
177430774
177442437
-
AC020909.1
chr19
50415799
50428409
+
ABHD17A
chr19
1876810
1885547
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-4751
chr19
49933073
49933096
+
hsa-miR-6850-5p
chr8
144791970
144791991
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005899.4
chr17
32328441
32329395
+
AC007952.4
chr17
19112000
19112636
-
AC016876.2
chr17
7581964
7584086
-
AC021242.3
chr8
9555144
9556520
-
AC026362.1
chr12
122975320
122982907
+
AC026461.1
chr16
56682470
56687807
+
AC060780.1
chr17
43148368
43171037
-
AC067930.1
chr8
143579636
143580670
+
AC092329.1
chr19
23257255
23274232
-
AC092329.4
chr19
23259906
23274251
-
AC099778.1
chr3
47379089
47380999
-
AC105105.1
chr18
58535415
58538552
+
AC105285.1
chr4
173094868
173169652
-
AC132217.1
chr11
2129121
2129964
-
AD000090.1
chr19
35557956
35581954
+
AL021707.1
chr22
38739003
38749041
+
AL022311.1
chr22
37876148
37895563
+
AL132780.1
chr14
22929607
22956374
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA